Endometrial Cancer: Abnormal Bleeding, Diagnosis, and Surgery

Endometrial cancer is a cancer of the lining of the uterus and is often found early because it can cause abnormal vaginal bleeding. Diagnosis usually involves examining a tissue sample from the endometrium, and surgery is the main treatment for many patients.

Overview

Endometrial cancer begins in the endometrium, the inner lining of the uterus. The uterus is the organ where a pregnancy develops, and the endometrium normally thickens and sheds during the menstrual cycle. When cells in this lining grow in an uncontrolled way, a tumor can form.

It is the most common type of uterine cancer. Many cases are found at an early stage because the disease often causes abnormal vaginal bleeding, especially bleeding after menopause. Early diagnosis can make treatment more straightforward, but every patient’s situation is different and requires an individualized plan.

Endometrial cancer is not the same as cervical cancer, ovarian cancer, or uterine sarcoma, although all are gynecologic cancers. The exact type of tumor, its grade, and whether it has spread help doctors decide which treatments are most appropriate.

Symptoms and Abnormal Bleeding

The most important warning sign of endometrial cancer is abnormal uterine or vaginal bleeding. In people who have gone through menopause, any vaginal bleeding is considered abnormal and should be evaluated. This includes spotting, pink or brown discharge, bleeding after sex, or a single light episode.

Before menopause, warning signs may include unusually heavy periods, bleeding between periods, periods that become much longer than usual, or bleeding patterns that change without a clear reason. These symptoms are common and may be caused by non-cancerous conditions such as fibroids, polyps, hormonal changes, or infection, but they should not be ignored.

Other possible symptoms can include watery or blood-tinged vaginal discharge, pelvic discomfort, pain during intercourse, or unexplained pelvic pressure. More advanced disease may cause fatigue, changes in urination or bowel habits, abdominal swelling, or unintended weight loss, although these symptoms can also occur with many other health conditions.

• Bleeding after menopause needs medical assessment.
• New bleeding between periods should be discussed with a doctor.
• Persistent unusual discharge should be checked, even without pain.
• Severe pelvic pain or heavy bleeding requires prompt medical care.

Causes and Risk Factors

Endometrial cancer develops when changes occur in the DNA of endometrial cells, allowing them to multiply abnormally. In many cases, growth of the endometrium is influenced by estrogen. When estrogen is not balanced by enough progesterone, the lining may become thicker over time, which can increase the chance of abnormal cell changes.

Risk factors include older age, being after menopause, obesity, conditions associated with irregular ovulation such as polycystic ovary syndrome, early first menstrual period, late menopause, never having been pregnant, and a history of endometrial hyperplasia. Type 2 diabetes and high blood pressure are also often seen in people with endometrial cancer, partly because they can be linked with metabolic health and body weight.

Some medications and medical histories can increase risk. Tamoxifen use for breast cancer, estrogen therapy without progesterone in someone who has a uterus, and certain inherited conditions such as Lynch syndrome are important examples. A family history of colorectal, endometrial, or related cancers may suggest a need for genetic counseling.

Having one or more risk factors does not mean a person will develop endometrial cancer, and some people with the disease have no obvious risk factors. Risk assessment is used to guide timely evaluation, prevention strategies, and follow-up when needed.

How Endometrial Cancer Is Diagnosed

Diagnosis begins with a medical history and pelvic examination. The doctor will ask about bleeding patterns, menopause status, medications, pregnancies, family history, and other health conditions. Because symptoms can overlap with benign gynecologic problems, tissue testing is usually needed to confirm or rule out cancer.

An endometrial biopsy is a common diagnostic test. During this procedure, a thin instrument is passed through the cervix to collect a small sample from the uterine lining. The sample is examined by a pathologist to look for cancer cells, precancerous changes, tumor type, and sometimes features that help guide treatment.

Transvaginal ultrasound may be used to measure the thickness of the endometrium and look for other causes of bleeding, such as polyps or fibroids. If the biopsy is not possible, does not provide enough tissue, or symptoms continue despite reassuring results, hysteroscopy and dilation and curettage may be recommended. Hysteroscopy allows the doctor to look inside the uterus with a small camera and take targeted samples.

Once cancer is diagnosed, imaging tests such as MRI, CT, PET/CT, or chest imaging may be used in selected cases to assess whether the cancer has spread. Blood tests and general health evaluation help prepare for treatment. Final staging is often determined after surgery, when the uterus and any sampled lymph nodes are examined.

Treatment Options and Surgery

Treatment depends on the stage, tumor grade, cancer subtype, molecular test results, age, overall health, and personal preferences. For many patients, surgery is the main treatment. The typical operation is a hysterectomy, which removes the uterus, often together with removal of both fallopian tubes and ovaries. The cervix is usually removed as part of a total hysterectomy.

During surgery, the gynecologic oncology team may also assess lymph nodes to see whether cancer has spread. Many centers use sentinel lymph node mapping, a technique that identifies the first lymph nodes most likely to receive drainage from the uterus. In some cases, more extensive lymph node removal or removal of nearby tissue may be needed.

Surgery may be performed through an open abdominal incision, laparoscopy, or robotic-assisted minimally invasive surgery. The best approach depends on cancer factors, body anatomy, previous operations, and the surgeon’s judgment. Minimally invasive surgery can be appropriate for many early-stage cases, but safety and complete cancer treatment are always the priority.

Some patients need additional therapy after surgery. Radiation therapy may reduce the risk of cancer returning in the pelvis or vagina. Chemotherapy may be recommended for higher-risk, advanced, or certain aggressive tumor types. Hormone therapy, targeted therapy, or immunotherapy may be considered in selected cases, particularly when molecular testing shows features that predict benefit.

Recovery, Follow-Up, and Life After Treatment

Recovery after endometrial cancer surgery varies according to the type of operation and a person’s general health. Patients may need time to regain energy, manage temporary discomfort, and gradually return to normal activities. The care team usually provides instructions about wound care, movement, lifting, bathing, driving, and when sexual activity can safely resume.

If the ovaries are removed before natural menopause, menopause begins immediately. Symptoms can include hot flashes, sleep changes, vaginal dryness, and mood changes. Hormone therapy may not be suitable for everyone after endometrial cancer, so any menopausal symptoms should be discussed with the treating doctor to find safe options.

Follow-up visits are important after treatment. These appointments allow the doctor to review symptoms, perform examinations, monitor recovery, and address emotional, sexual, urinary, bowel, or lymphatic concerns. Patients are encouraged to report new bleeding, persistent pelvic pain, unexplained weight loss, swelling of the legs, or ongoing cough rather than waiting for the next scheduled appointment.

Prevention and Self-Care

There is no guaranteed way to prevent endometrial cancer, but some risk factors can be modified. Maintaining a healthy weight, staying physically active, and managing diabetes or insulin resistance may help reduce risk. Even modest, sustainable lifestyle changes can support overall health and may improve recovery if treatment is ever needed.

People with irregular periods, polycystic ovary syndrome, or prolonged absence of periods should speak with a doctor about protecting the endometrium. In some cases, progesterone-containing treatments or other medical strategies may be recommended. Anyone using hormone therapy after menopause should use it only under medical supervision, especially if they still have a uterus.

People with a strong family history of endometrial, colorectal, ovarian, stomach, or related cancers may benefit from genetic counseling to assess the possibility of Lynch syndrome or another hereditary cancer condition. When risk is inherited, doctors can recommend tailored screening, prevention, and family guidance.

Self-care also means acting promptly on symptoms. Keeping a simple record of bleeding dates, flow, pain, medications, and menopause status can help the doctor understand what is happening and choose the right tests.

When to See a Doctor

A doctor should be consulted for any bleeding after menopause, bleeding between periods, unusually heavy or prolonged periods, or persistent watery or blood-stained discharge. These symptoms often have non-cancerous causes, but checking them early is the safest approach.

Urgent medical care is needed for very heavy bleeding, dizziness, fainting, severe pelvic pain, fever, or symptoms that feel rapidly worsening. People who are taking blood thinners or who have a known bleeding disorder should seek advice promptly if new bleeding occurs.

Patients diagnosed with endometrial cancer should ideally be cared for by a gynecologic oncologist or a multidisciplinary cancer team. Near the end of evaluation or treatment planning, international patients may consider centers such as Acibadem International, where multidisciplinary specialists and JCI-accredited hospitals diagnose and treat gynecologic cancers. Decisions should always be made after a full medical assessment and discussion of risks, benefits, and alternatives.

Frequently asked questions

Is bleeding after menopause always a sign of endometrial cancer?

No. Bleeding after menopause can be caused by thinning vaginal tissues, polyps, medications, infection, or other benign conditions. However, it is always considered abnormal and should be assessed to rule out endometrial cancer or precancerous changes.

How is endometrial cancer confirmed?

Endometrial cancer is confirmed by examining tissue from the uterine lining under a microscope. This tissue is usually obtained with an endometrial biopsy, hysteroscopy, or dilation and curettage. Imaging tests can support evaluation but do not replace tissue diagnosis.

Will every patient need a hysterectomy?

Most patients with endometrial cancer are treated with hysterectomy because it removes the organ where the cancer began and helps determine the stage. In carefully selected young patients with very early, low-risk disease who want future pregnancy, fertility-sparing hormone treatment may be considered. This option requires close specialist supervision and is not suitable for all tumor types.

What is sentinel lymph node mapping?

Sentinel lymph node mapping is a surgical technique used to identify the first lymph nodes that drain the uterus. These nodes are removed and examined to check whether cancer has spread. It can provide staging information while potentially avoiding more extensive lymph node surgery in selected patients.

Can endometrial cancer come back after treatment?

Yes, recurrence is possible, although the risk varies widely depending on stage, grade, tumor biology, and treatment. Follow-up visits help detect concerning symptoms and manage recovery-related issues. New vaginal bleeding, pelvic pain, persistent cough, or unexplained weight loss should be reported to the care team.

Are Pap smears used to screen for endometrial cancer?

Pap smears are designed to screen for cervical cancer, not endometrial cancer. Occasionally, a Pap test may show abnormal glandular cells that lead to further evaluation of the uterus. A normal Pap smear does not rule out endometrial cancer if abnormal bleeding is present.

References

• American Cancer Society
• National Cancer Institute
• European Society for Medical Oncology
• American College of Obstetricians and Gynecologists
• World Health Organization

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.